MedPath

Remote monitoring in rheumatoid arthritis for early detection of flare, does remote patient-reported flare assessment agree with clinician flare assessment?

Not Applicable
Conditions
Rheumatoid arthritis
Musculoskeletal Diseases
Registration Number
ISRCTN15980128
Lead Sponsor
Royal United Hospitals Bath NHS Foundation Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
100
Inclusion Criteria

1. Can access and operate an Android or iOS operating system smartphone or tablet device
2. Access to the internet
3. An active email account
4. Capacity to consent to participate in the study
5. Able to attend face-to-face appointments 3-monthly and within three days of onset of a flare
6. Able to complete the remote monitoring according to the documented schedule
7. English language proficiency to use the smartphone application and complete remote data entry

Exclusion Criteria

1. Fibromyalgia syndrome (FMS). The symptomatology of this condition can be a source of confounding of patient-reported outcome measures (PROMs) in rheumatoid arthritis.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath